Thomas Ryan M, Ahmad Syed A
Department of Surgery, Division of Surgical Oncology, University of Cincinnati College of Medicine, University of Cincinnati, 231 Albert Sabin Way, ML 0558, Cincinnati, OH 45267-0558, USA.
Surg Oncol Clin N Am. 2010 Apr;19(2):335-58. doi: 10.1016/j.soc.2009.11.001.
Pancreatic ductal adenocarcinoma (PDA) is the most common pancreatic malignancy comprising approximately 85% of cases. Many aspects of surgical resection of pancreatic cancer have been evaluated as to their effects on morbidity and mortality, including evaluation of anastomotic techniques, the role of extended lymphadenectomies, and the use of vascular reconstruction. Progress in the perioperative care of those undergoing pancreatic resection for PDA has resulted in improved outcomes. This review discusses the preoperative evaluation of a patient with pancreatic cancer and addresses the surgical management of these patients, with special attention to recent areas of progress and controversy.
胰腺导管腺癌(PDA)是最常见的胰腺恶性肿瘤,约占病例的85%。胰腺癌手术切除的许多方面已就其对发病率和死亡率的影响进行了评估,包括吻合技术的评估、扩大淋巴结清扫的作用以及血管重建的应用。接受PDA胰腺切除术患者围手术期护理的进展已带来更好的结果。本综述讨论了胰腺癌患者的术前评估,并阐述了这些患者的手术管理,特别关注近期取得进展和存在争议的领域。